MR-PRP
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Jan 2025)
What this means for you
Registered since 04 Sept 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Sept 2028: the §8 & §9 renewal).
Record
- Serial number
- 87496192
- Registration number
- 5556709
- Mark type
- Word mark
- Filed
- 19 Jun 2017
- Published for opposition
- 05 Dec 2017
- Registered
- 04 Sept 2018
- Next maintenance filing
- §8 & §9 renewal, due by 04 Sept 2028 (grace period to 04 Mar 2029)
- Attorney of record
- Stacey R. Halpern
Goods and services
- Class 005 — Pharmaceuticals: Platelet rich blood plasma; Pharmaceutical preparations for treatment and prevention of tissue injuries, disorders, and diseases, and for promotion of cell and tissue regeneration; Medicaments for promoting recovery from tissue injuries, disorders, and diseases, and to help assist with the regeneration of cells and tissue
Owner
- Mishra, Allan, Menlo Park, CA, US
- Mishra, Allan, Menlo Park, CA, US
- Mishra, Allan, Menlo Park, CA, US
Prosecution history
- 22 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Aug 2024 — TEAS SECTION 8 & 15 RECEIVED
- 04 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 03 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Aug 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jul 2018 — USE AMENDMENT FILED
- 01 Aug 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 30 Jan 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Dec 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Dec 2017 — PUBLISHED FOR OPPOSITION